Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AMA (Association of Medicine and Analytics) is a specialized medical manufacturing company focused on the development and production of diagnostic systems for gastroenterology. Founded in 1997 and headquartered in Saint Petersburg, Russia, the company is a global leader in rapid urease tests (RUT) and non-invasive breath tests for the detection of Helicobacter pylori. Their flagship products, including the AMA RUT and the AMA HELIC breath test, are widely utilized in clinical settings to diagnose conditions such as gastritis and peptic ulcers. Additionally, AMA manufactures high-precision pH-meters for endoscopic and peripheral use, supporting comprehensive digestive health diagnostics. The company maintains ISO 13485 certification and exports its diagnostic solutions to numerous international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AMA Medical Manufacturing.